Translational and First-in-Human Positron Emission Tomography Targeting Prostatic Acid Phosphatase in Prostate Cancer Using the Ligand [68Ga]Ga-OncoACP3-DOTA.

Saved in:
Bibliographic Details
Title: Translational and First-in-Human Positron Emission Tomography Targeting Prostatic Acid Phosphatase in Prostate Cancer Using the Ligand [68Ga]Ga-OncoACP3-DOTA.
Authors: Backhaus P; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany; European Institute of Molecular Imaging, University of Münster, Münster, Germany. Electronic address: philipp.backhaus@ukmuenster.de., Cazzamalli S; Philochem AG, Otelfingen, Switzerland., Oehler S; Philochem AG, Otelfingen, Switzerland., Büther F; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany; European Institute of Molecular Imaging, University of Münster, Münster, Germany., Brosch-Lenz J; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany., Landau F; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany; European Institute of Molecular Imaging, University of Münster, Münster, Germany., Breyholz HJ; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany., Claesener M; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany., Migliorini F; Philochem AG, Otelfingen, Switzerland., Ciamarone A; Philochem AG, Otelfingen, Switzerland., Georgiev T; Philochem AG, Otelfingen, Switzerland., Mock J; Philochem AG, Otelfingen, Switzerland., Ventura D; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany; European Institute of Molecular Imaging, University of Münster, Münster, Germany., Barca C; European Institute of Molecular Imaging, University of Münster, Münster, Germany., Schiefelbein L; European Institute of Molecular Imaging, University of Münster, Münster, Germany., Hermann S; European Institute of Molecular Imaging, University of Münster, Münster, Germany., Schäfers K; European Institute of Molecular Imaging, University of Münster, Münster, Germany., Gierse F; European Institute of Molecular Imaging, University of Münster, Münster, Germany., Bernemann C; Department of Urology, University Hospital Münster, Münster, Germany., Schlack K; Department of Urology, University Hospital Münster, Münster, Germany., Bögemann M; Department of Urology, University Hospital Münster, Münster, Germany., Puca E; Philochem AG, Otelfingen, Switzerland., Schindler P; Department of Radiology, University Hospital Münster, Münster, Germany., Neri D; Philochem AG, Otelfingen, Switzerland., Rahbar K; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany., Schrader AJ; Department of Urology, University Hospital Münster, Münster, Germany., Seifert KE; European Institute of Molecular Imaging, University of Münster, Münster, Germany; Department of Urology, University Hospital Münster, Münster, Germany., Schäfers M; Department of Nuclear Medicine, University Hospital Münster, Münster, Germany; European Institute of Molecular Imaging, University of Münster, Münster, Germany.
Source: European urology [Eur Urol] 2026 Apr; Vol. 89 (4), pp. 305-310. Date of Electronic Publication: 2025 Dec 17.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7560
DOI:10.1016/j.eururo.2025.11.025